Temporal effect of afro-caribbean race on serum pregnancy-associated plasma protein-A at 9-13 weeks' gestation in screening for aneuploidies

Fetal Diagnosis and Therapy

Volumn 31, Issue 3, 2012, Pages 162-169

  Ball, Susan ^a   Wright, David ^a   Sodre, Danielle ^b,c   Lachmann, Robert ^b,c   Nicolaides, Kypros H ^b,c  

^a UNIVERSITY OF PLYMOUTH   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

First trimester screening; Free human chorionic gonadotropin; Nuchal translucency; Pregnancy associated plasma protein A

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PLACENTAL GROWTH FACTOR; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; AFRICAN CARIBBEAN; ANEUPLOIDY; ARTICLE; BODY WEIGHT; CAUCASIAN; CHROMOSOME; CONCEPTION; FEMALE; FERTILIZATION IN VITRO; GENE DELETION; GENE TRANSLOCATION; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL SMOKING; MOSAICISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCHAL TRANSLUCENCY MEASUREMENT; PARITY; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RACE; SEX CHROMOSOME ABERRATION; TRIPLOIDY; TRISOMY 13; TRISOMY 18; TRISOMY 21;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ANEUPLOIDY; BIOLOGICAL MARKERS; CARIBBEAN REGION; CHI-SQUARE DISTRIBUTION; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DIABETES MELLITUS, TYPE 2; ENGLAND; FEMALE; GENETIC TESTING; GESTATIONAL AGE; HUMANS; NUCHAL TRANSLUCENCY MEASUREMENT; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 84860343190     PISSN: 10153837     EISSN: 14219964     Source Type: Journal    
DOI: 10.1159/000336252     Document Type: Article

References (19)

1. Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH: A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 1999; 13: 231-237. (Pubitemid 29248329)
2. Kagan KO, Wright D, Valencia C, Maiz N, Nicolaides KH: Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A. Hum Reprod 2008; 23: 1968-1975.
3. Wright D, Spencer K, Kagan KK, Tørring N, Petersen OB, Christou A, Kallikas J, Nicolaides KH: First-trimester combined screening for trisomy 21 at 7-14 weeks' gestation. Ultrasound Obstet Gynecol 2010; 36: 404-411.
4. Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH: First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol 2008; 31: 493-502.
5. Pandya P, Wright D, Syngelaki A, Akolekar R, Nicolaides KH: Maternal serum placental growth factor in prospective screening for aneuploidies at 8-13 weeks' gestation. Fetal Diagn Ther, in press.
6. Robinson HP, Fleming JE: A critical evaluation of sonar crown rump length measurements. Br J Obstet Gynaecol 1975; 82: 702-710.
7. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH: Fetal Medicine Foundation First Trimester Screening Group. 2008. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchaltranslucency thickness at 10-14 weeks of gestation. Lancet 1998; 352: 343-346. (Pubitemid 28352196)
8. Syngelaki A, Chelemen T, Dagklis T, Allan LD, Nicolaides KH: Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11-13 weeks. Prenat Diagn 2011; 31: 90-102.
9. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM: The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001; 20:IX-XIV. (Pubitemid 32672922)
10. Poon LC, Karagiannis G, Staboulidou I, Shafiei A, Nicolaides KH: Reference range of birth weight with gestation and first-trimester prediction of small for gestation neonates. Prenat Diagn 2011; 31: 58-65.
11. Wright D, Kagan KO, Molina FS, Gazzoni A, Nicolaides KH: A mixture model of nuchal translucency thickness in screening for chromosomal defects. Ultrasound Obstet Gynecol 2008; 31: 376-383.
12. Office for National Statistics. Birth Statistics. Review of the Registrar General on Births and Patterns of Family Building in England and Wales. Series FM1, Nos 29-31. London, Stationary Office, 2000-2002.
13. R Development Core Team. R: A language and environment for statistical computing. Vienna, R Foundation for Statistical Computing, 2011. ISBN 3-900051-07-0. http://www.R-project.org/. 2011.
14. Ong CY, Liao AW, Spencer K, Munim S, Nicolaides KH: First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. BJOG 2000; 107: 1265-1270.
15. Spencer K, Cicero S, Atzei A, Otigbah C, Nicolaides KH: The influence of maternal insulin-dependent diabetes on fetal nuchal translucency thickness and first-trimester maternal serum biochemical markers of aneuploidy. Prenat Diagn 2005; 25: 927-929. (Pubitemid 41494989)
16. Spencer K, Cowans NJ, Spencer CE, Achillea N: A re-evaluation of the influence of maternal insulin-dependent diabetes on fetal nuchal translucency thickness and first-trimester maternal serum biochemical markers of aneuploidy. Prenat Diagn 2010; 30: 937-940.
17. Kuc S, Wortelboer E, Koster M, de Valk H, Schielen P, Visser G: Prediction of macrosomia at birth in type-1 and 2 diabetic pregnancies with biomarkers of early placentation. BJOG 2011; 118: 748-754.
18. Pedersen JF, Sørensen S, Mølsted-Pedersen L: Serum levels of human placental lactogen, pregnancy-associated plasma protein A and endometrial secretory protein PP14 in first trimester of diabetic pregnancy. Acta Obstet Gynecol Scand 1998; 77: 155-158. (Pubitemid 28075381)
19. Spencer K: The influence of smoking on maternal serum AFP and free beta hCG levels. Prenat Diagn 1998; 18: 225-234.